Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Szatanik, Marek ^a   Hong, Eva ^a   Ruckly, Corinne ^a   Ledroit, Morgan ^a   Giorgini, Dario ^a   Jopek, Katarzyna ^a,b   Nicola, Marie Anne ^a   Deghmane, Ala Eddine ^a   Taha, Muhamed Kheir ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; TRANSFERRIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BAGG ALBINO MOUSE; BLOOD SAMPLING; BRAIN; DISEASE MODEL; ENZYME INDUCTION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; INFLUENZA A; MALE; MENINGOCOCCEMIA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TRANSGENIC MOUSE; ANIMAL; BACTERIAL COUNT; BLOOD; CONGENIC STRAIN; EXPOSURE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFLUENZA VIRUS A; INTRAPERITONEAL DRUG ADMINISTRATION; MENINGOCOCCOSIS; METABOLISM; NEISSERIA MENINGITIDIS; PATHOLOGY; PHYSIOLOGY; SEPSIS; SURVIVAL; VIROLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS; MUS; MUS MUSCULUS;

ANIMALS; BRAIN; COLONY COUNT, MICROBIAL; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA A VIRUS; INHALATION EXPOSURE; INJECTIONS, INTRAPERITONEAL; MENINGOCOCCAL INFECTIONS; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, TRANSGENIC; NEISSERIA MENINGITIDIS; SEPSIS; SURVIVAL ANALYSIS; TRANSFERRIN;

EID: 79960624165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022210     Document Type: Article

References (34)

1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM, (2001) Meningococcal disease. N Engl J Med 344: 1378-1388.
2. van Deuren M, Brandtzaeg P, van der Meer JW, (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13: 144-166 table of contents.
3. Johansson L, Rytkonen A, Bergman P, Albiger B, Kallstrom H, et al. (2003) CD46 in meningococcal disease. Science 301: 373-375.
4. Zarantonelli ML, Szatanik M, Giorgini D, Hong E, Huerre M, et al. (2007) Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun 75: 5609-5614.
5. Deghmane AE, Parent du Chatelet I, Szatanik M, Hong E, Ruckly C, et al. (2010) Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France. J Infect Dis 202: 247-250.
6. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
7. Brun-Buisson C, Meshaka P, Pinton P, Vallet B, (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30: 580-588.
8. Schuerholz T, Marx G, (2008) Management of sepsis. Minerva Anestesiol 74: 181-195.
9. Kellogg DS Jr, Peacock WL Jr, Deacon WE, Brown L, Pirkle DI, (1963) Neisseria gonorrhoeae. I. Virulence Genetically Linked to Clonal Variation. J Bacteriol 85: 1274-1279.
10. Hanahan D, (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166: 557-580.
11. Taha MK, Morand PC, Pereira Y, Eugene E, Giorgini D, et al. (1998) Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein. Mol Microbiol 28: 1153-1163.
12. Taha MK, So M, Seifert HS, Billyard E, Marchal C, (1988) Pilin expression in Neisseria gonorrhoeae is under both positive and negative transcriptional control. Embo J 7: 4367-4378.
13. Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, et al. (2003) A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol Lett 222: 99-106.
14. Cheadle C, Vawter MP, Freed WJ, Becker KG, (2003) Analysis of microarray data using Z score transformation. J Mol Diagn 5: 73-81.
15. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA, (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
16. Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, et al. (2009) Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun 77: 3588-3595.
17. Hubert B, Watier L, Garnerin P, Richardson S, (1992) Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 166: 542-545.
18. Lee SM, Chan RW, Gardy JL, Lo CK, Sihoe AD, et al. (2010) Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res 11: 147.
19. Schneider MC, Prosser BE, Caesar JJ, Kugelberg E, Li S, et al. (2009) Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458: 890-893.
20. Schneider MC, Exley RM, Ram S, Sim RB, Tang CM, (2007) Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 15: 233-240.
21. Granoff DM, Welsch JA, Ram S, (2009) Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun 77: 764-769.
22. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
23. Takeda K, Akira S, (2004) Microbial recognition by Toll-like receptors. J Dermatol Sci 34: 73-82.
24. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
25. Liew FY, Xu D, Brint EK, O'Neill LA, (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5: 446-458.
26. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, et al. (2006) Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 116: 2532-2542.
27. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, et al. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88: 1747-1754.
28. Escoll P, del Fresno C, Garcia L, Valles G, Lendinez MJ, et al. (2003) Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 311: 465-472.
29. Marques F, Rodrigues AJ, Sousa JC, Coppola G, Geschwind DH, et al. (2008) Lipocalin 2 is a choroid plexus acute-phase protein. J Cereb Blood Flow Metab 28: 450-455.
30. Reigstad CS, Lunden GO, Felin J, Backhed F, (2009) Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS One 4: e5842.
31. Grassme H, Jendrossek V, Gulbins E, (2001) Molecular mechanisms of bacteria induced apoptosis. Apoptosis 6: 441-445.
32. Deghmane AE, Veckerle C, Giorgini D, Hong E, Ruckly C, et al. (2009) Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis. PLoS Pathog 5: e1000405.
33. Li P, Jayarama S, Ganesh L, Mordi D, Carr R, et al. (2010) Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4. J Biol Chem 285: 22713-22722.
34. Seki M, Higashiyama Y, Tomono K, Yanagihara K, Ohno H, et al. (2004) Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol 137: 35-40.